News Focus
News Focus
Followers 35
Posts 2238
Boards Moderated 0
Alias Born 10/18/2019

Re: Reefrad post# 618292

Tuesday, 08/08/2023 8:16:07 AM

Tuesday, August 08, 2023 8:16:07 AM

Post# of 823528
Reefrad, very logical post based on facts from the trial. The 3 month median improvement in OS is significant if not spectacular with a favorable safety profile. Temodar became part of SOC with the same 3 month improvement in median OS. Dcvax along with adjuvants hold much potential for further improvement but they were not part of the trial and imo such a trial should be conducted in the future. Nwbo really (imo) need to get their consultants preparing submission(s) for approval to move faster and let the regulators decide. I think they will approve but only if applications are submitted. As Dr Liau has said this awful disease needs multiple treatment approaches and dcvax I think should be one of them
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News